AIA
TEVA icon

AIMZ Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

AIMZ Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.22M Sell
212,978
-2,000
-0.9% -$66.6K 1.99% 13
2026
Q1 		$6.48M Sell
214,978
-5,558
-3% -$179K 2% 11
2025
Q4 		$6.88M Sell
220,536
-1,750
-0.8% -$43.1K 1.97% 10
2025
Q3 		$4.49M Sell
222,286
-2,271
-1% -$39.9K 1.41% 25
2025
Q2 		$3.76M Sell
224,557
-1,400
-0.6% -$22.6K 1.26% 26
2025
Q1 		$3.47M Sell
225,957
-617
-0.3% -$11K 1.21% 28
2024
Q4 		$4.99M Sell
226,574
-1,050
-0.5% -$19.1K 1.73% 14
2024
Q3 		$4.1M Sell
227,624
-1,700
-0.7% -$29.8K 1.4% 24
2024
Q2 		$3.73M Sell
229,324
-3,600
-2% -$55.4K 1.34% 22
2024
Q1 		$3.29M Sell
232,924
-100
-0% -$1.26K 1.23% 27
2023
Q4 		$2.43M Sell
233,024
-5,651
-2% -$52.8K 0.99% 35
2023
Q3 		$2.43M Sell
238,675
-716
-0.3% -$6.67K 1.08% 33
2023
Q2 		$1.8M Buy
239,391
+300
+0.1% +$2.43K 0.77% 44
2023
Q1 		$2.12M Sell
239,091
-1,500
-0.6% -$14.8K 0.95% 40
2022
Q4 		$2.19M Sell
240,591
-7,025
-3% -$61.3K 1.04% 38
2022
Q3 		$2M Sell
247,616
-900
-0.4% -$7.96K 1.01% 38
2022
Q2 		$1.87M Buy
248,516
+5,800
+2% +$50.5K 0.9% 40
2022
Q1 		$2.28M Buy
242,716
+3,336
+1% +$27.8K 0.94% 39
2021
Q4 		$1.92M Buy
239,380
+66,314
+38% +$599K 0.75% 46
2021
Q3 		$1.69M Sell
173,066
-3,917
-2% -$36.7K 0.76% 46
2021
Q2 		$1.75M Buy
176,983
+1,300
+0.7% +$13.8K 0.79% 44
2021
Q1 		$2.03M Sell
175,683
-600
-0.3% -$6.88K 0.99% 39
2020
Q4 		$1.7M Sell
176,283
-4,400
-2% -$42.2K 0.89% 39
2020
Q3 		$1.63M Buy
180,683
+3,950
+2% +$41.8K 0.97% 38
2020
Q2 		$2.18M Sell
176,733
-300
-0.2% -$3.39K 1.41% 29
2020
Q1 		$1.59M Sell
177,033
-100
-0.1% -$1.02K 1.24% 32
2019
Q4 		$1.74M Sell
177,133
-9,350
-5% -$83.5K 1.12% 32
2019
Q3 		$1.28M Sell
186,483
-1,100
-0.6% -$8.43K 0.88% 44
2019
Q2 		$1.73M Buy
187,583
+59,888
+47% +$722K 1.19% 30
2019
Q1 		$2M Sell
127,695
-100
-0.1% -$1.76K 1.37% 26
2018
Q4 		$1.97M Sell
127,795
-2,300
-2% -$47.2K 1.52% 23
2018
Q3 		$2.8M Sell
130,095
-100
-0.1% -$2.32K 1.8% 18
2018
Q2 		$3.17M Sell
130,195
-1,475
-1% -$30.1K 2.24% 12
2018
Q1 		$2.25M Sell
131,670
-350
-0.3% -$6.83K 1.63% 19
2017
Q4 		$2.5M Sell
132,020
-17,272
-12% -$260K 1.88% 16
2017
Q3 		$2.63M Buy
149,292
+63,202
+73% +$1.42M 2.15% 14
2017
Q2 		$2.86M Buy
86,090
+20,011
+30% +$619K 2.41% 10
2017
Q1 		$2.12M Buy
66,079
+8,161
+14% +$279K 1.79% 16
2016
Q4 		$2.1M Sell
57,918
-443
-0.8% -$17.7K 1.88% 17
2016
Q3 		$2.69M Sell
58,361
-95
-0.2% -$4.96K 2.4% 10
2016
Q2 		$2.94M Sell
58,456
-545
-0.9% -$29K 2.69% 5
2016
Q1 		$3.16M Sell
59,001
-796
-1% -$46.7K 2.86% 4
2015
Q4 		$3.92M Sell
59,797
-146
-0.2% -$9.02K 3.58% 1
2015
Q3 		$3.38M Sell
59,943
-1,096
-2% -$71.1K 3.11% 3
2015
Q2 		$3.61M Buy
61,039
+4
+0% +$247 3.13% 4
2015
Q1 		$3.8M Sell
61,035
-145
-0.2% -$8.43K 3.25% 4
2014
Q4 		$3.52M Buy
+61,180
New +$3.41M 3.14% 5

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

AIMZ Investment Advisors's TEVA Position: Q2 2026 in Review

AIMZ Investment Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 0.93% in Q2 2026, selling an estimated $66.6K and leaving 212,978 shares worth $7.22M. The position accounts for 1.99% of the portfolio, ranked #13.

AIMZ Investment Advisors first reported a position in TEVA in Q4 2014 and has held it in 47 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • AIMZ Investment Advisors held 212,978 shares of Teva Pharmaceuticals worth $7.22M as of Q2 2026.
  • AIMZ Investment Advisors sold 2,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $66.6K.
  • Teva Pharmaceuticals made up 1.99% of AIMZ Investment Advisors's portfolio in Q2 2026, its #13 holding.
  • AIMZ Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.